Skip to content
WeighLab
Menu

Head-to-head · Cost-Efficiency Index

Recovery Delivered vs Goldspan Health

Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.

Better valueGrade C · #71

Recovery Delivered

Shoppers who don't mind the price rising in step with their dose, outside the excluded states.

Visit Recovery Delivered
VS
Grade C · #77

Goldspan Health

Shoppers who want a sublingual route priced openly beside the injection and who will count 13 charges a year rather than 12.

Visit Goldspan Health

The verdict

Winner · Recovery DeliveredGrade C vs C

Recovery Delivered takes it, leading the Cost-Efficiency Index 72 to 71. Recovery Delivered is primarily an online addiction/recovery telehealth brand (buprenorphine treatment is its lead offering) that also runs a real, separately priced GLP-1 weight-loss vertical. Goldspan Health still earns a CShoppers who want a sublingual route priced openly beside the injection and who will count 13 charges a year rather than 12.

Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Recovery Delivered.

Factor by factor

Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.

Normalized Cost/Month

63
56

Price Transparency

78
86

Nationwide Access

66
86

Formulation Options

90
77

Clinical Oversight

79
68

Contract Flexibility

55
45

Pricing, coverage & formulary

The disclosed facts behind the scores. Lower price wins its row (teal).

SpecRecovery DeliveredGoldspan Health
Cost-Efficiency Index72/10071/100
Semaglutide / mo$199/mo (starting dose, compounded)$229 every 28 days month-to-month (13 charges a year, not 12)
Tirzepatide / mo$219/mo (1 mg dose, compounded)$299 every 28 days month-to-month (13 charges a year, not 12)
Semaglutide / yr (modeled)$2,388$2,748
Tirzepatide / yr (modeled)$2,628$3,588
Coverage32 statesAll 50 states
Oral / sublingualYesYes
Brand-name accessYesCompounded only
Rank here#71#77

Recovery Delivered

72/100

Where the value is

  • Every dose tier's price is published month-by-month rather than hidden behind a single 'starting at' figure
  • Visit, medication, injection kit, and delivery are stated as bundled into each tier with no itemized add-ons found
  • Oral (drops/tablets) alternative offered alongside injectable, starting at $249/month

The tradeoffs

  • The $219.99/$199.99 headline figures are STARTING-dose prices only — the site's own tiers show cost rising to $299.99/month by month 5 as the dose increases, so the true steady-state cost for most patients is meaningfully higher than the headline
  • Explicitly unavailable in at least 19 states including California, Illinois, and Michigan — not a 50-state provider
Visit Recovery Delivered

Full Recovery Delivered review →

Goldspan Health

71/100

Where the value is

  • Prices ten separate GLP-1 products openly — injection and sublingual, standard and low dose, with a B12 or a glycine base — before any account
  • Each plan card itemizes what the figure buys: the clinician evaluation, the medication, injection supplies, two-day shipping and clinical-team access
  • States the billing cycle honestly on the plan card and the order timeline as 28 days and four weeks

The tradeoffs

  • The hero prints "/month" over a plan billed every 28 days, which is 13 charges a year rather than 12
  • "Pause, delay, or cancel at any time" sits against a refund policy reading "all sales are final" and storefront terms saying an order cannot be canceled once placed
Visit Goldspan Health

Full Goldspan Health review →

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.

Keep comparing

← All head-to-head comparisons